# Qualitek Labs share price today (Qualitek Labs Ltd, BSE: 544091)

> Qualitek Labs share price today: ₹502.00 at the BSE close on 3 November 2026. Qualitek Labs (BSE: 544091) is worth ₹585 crore and trades at a P/E of 72.5. > Qualitek Labs Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. 544091 · Miscellaneous · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/qualitek-labs-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: ₹502.00
- P/E: 72.5× (higher than 53% of the last 2.7 years)
- Revenue (Mar 2026): ₹38.6 Cr (+54.9% on a year ago)
- Profit (Mar 2026): ₹5.2 Cr (+44.8% on a year ago)
- Operating margin: 25.9% (−3.0 points on a year ago)
- ROCE: 8%, FY26
- ROIC: 9.6%, against a 12.0% cost of capital: −2.4 points
- Profit that came in as cash: 118%, last 3 years

The main question: promoters moved −16.9 percentage points over 5 quarters while the business went the other way. ## What is the Qualitek Labs share price today? Qualitek Labs Ltd's share price was ₹502.00 at the close on 3 November 2026. It has been rising for 23 weeks. That is 12.9% above its average price over the last 200 trading days. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 16 weeks in a row. Since its first close in our records, on 8 May 2026, it has traded between ₹340 and ₹621, and at that close it sat 58% of the way up from that low. Over the last 6 months the share price moved +48% while the NIFTY 500 moved −3%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Qualitek Labs this quarter? Two changes stood out: revenue up on a year earlier for 5 quarters in a row (every quarter we can compare) and operating margin down 3 points on a year earlier. 1. Revenue up on a year earlier for 5 quarters in a row (every quarter we can compare) In the March 2026 quarter revenue was ₹39 crore, +54.9% on a year earlier. 2. Operating margin down 3 points on a year earlier 26% in the March 2026 quarter, from 29%. ## What are Qualitek Labs' latest quarterly results? For January to March 2026 (the quarter ended 31 March 2026), Qualitek Labs reported revenue of ₹38.6 crore, up 54.9% from ₹24.9 crore a year earlier, and a profit of ₹5.17 crore, up 44.8% from ₹3.57 crore. ### Qualitek Labs results: January to March 2026 against a year earlier

| Measure | January to March 2026 | January to March 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹38.6 crore | ₹24.9 crore | +54.9% |
| Profit | ₹5.17 crore | ₹3.57 crore | +44.8% |
| Earnings per share | ₹4.44 | ₹3.58 | +24.0% |
| Operating margin | 25.9% | 29.0% | −3.0 points |

The next results, for April to June 2026, were due by 14 August 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). This page shows them once our weekly data update has read them. (From the company's reported quarterly results (quarter ended 31 March 2026). Revenue and profit in ₹ crore.)

## What is the Qualitek Labs share price history? Qualitek Labs closed at ₹502.00 on 3 November 2026. Its highest weekly close since May 2026 was ₹621.00 on 25 September 2026. ### Qualitek Labs share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹525.00 | −4.4% |
| 1 month ago · 1 Oct 2026 | ₹579.00 | −13.3% |
| 6 months ago · 8 May 2026 | ₹340.00 | +47.6% |
| Earliest and lowest weekly close in our records · 8 May 2026 | ₹340.00 | +47.6% |
| Highest weekly close since May 2026 · 25 Sep 2026 | ₹621.00 | −19.2% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (29 weekly closes from 8 May 2026 to 3 November 2026.)

## What is the latest news on Qualitek Labs? 3 Nov 2026: Qualitek Labs closed at ₹502.00, down 4.4% on the week and down 13.3% on the month. Our read, 10 Oct 2026: Reported expansion is visible, but acquisition effects, funding needs and limited reporting history prevent a confirmed self-funded growth thesis. ### Earlier

- Results for January to March 2026: Revenue up 54.9% and profit up 44.8% on a year earlier. ### Our read of the business

January to March 2026: Reported second-half profitability improved; this is a half-year observation. (Our read after the January to March 2026 results, written 10 October 2026.)

## What dividend does Qualitek Labs pay? No. Qualitek Labs Ltd paid out 0% of its profit as dividends in each of its last 6 reported years, so there is no payout history to show. That comes from the filed annual statements, not an estimate (as of 3 November 2026). ## What did Qualitek Labs management say on the latest results call? Qualitek Labs' management made 0 promises we could check against what it later reported. (Our read after the January to March 2026 results, written 10 October 2026.)

## What is the future of Qualitek Labs? What is changing in the business? What is changing at Qualitek Labs, from the latest results and calls: reported platform expansion, potential improvement in service economics and cash conversion of existing earnings. - Reported platform expansion. Revenue and operating profit increased together. ⚠ estimate
- Cash conversion of existing earnings. Operating cash broadly tracks profit before expansion spending. ⚠ estimate
- Forward execution goal. A numerical growth and profit-margin goal makes the next annual result testable. ⚠ estimate

We check 16 kinds of change in every company, such as costs spread over more sales, higher-value products, new orders, new regions or falling debt, against its reported numbers and what management said on its calls. Only changes the numbers back are shown. (Our read after the January to March 2026 results, written 10 October 2026.)

## What could change the Qualitek Labs story? What are the risks? A comparable reporting period showing lower operating profit while borrowings and overdue receivables increase would break the case that expansion is creating sustainable shareholder value. ### Each change stops working if

- Reported platform expansion: Comparable revenue stalls while depreciation, interest and operating costs continue rising. - Cash conversion of existing earnings: Operating cash falls behind profit while receivable ageing deteriorates. - Forward execution goal: Management reduces its goal or the comparable result fails to show the required operating contribution. ### The main risks

- : The thin-history lead remains unresolved. ⚠ estimate
- : Cash conversion does not establish self-funded expansion. ⚠ estimate
- : Collections remain a material use of capital. ⚠ estimate
- : Reported scale can outrun per-share value creation. ⚠ estimate

(Our read after the January to March 2026 results, written 10 October 2026.)

## What to watch in Qualitek Labs' next results? When Qualitek Labs reports April to June 2026, these are the 5 checks that show whether the story is still on course. First: The next filing still lacks an acquisition-adjusted comparison and a usable prior-period bridge. - What to check ()
- The next filing still lacks an acquisition-adjusted comparison and a usable prior-period bridge. - Borrowings increase faster than operating cash while returns on capital fail to improve. - Debtor days or overdue balances increase in the next comparable filing. - Further shares are issued without a disclosed attributable-profit contribution. - The next presentation omits inspection revenue, signed assignments and cash contribution. ## Which stock lists is Qualitek Labs on? Qualitek Labs is on one of our India lists: Multibagger study list. [Multibagger study list Study stage: middle](https://www.sectoralpha.in/multibagger-stocks-india)

## Is Qualitek Labs profitable? Qualitek Labs Ltd earned ₹5.2 Cr of net profit in the Mar 2026 quarter, +44.8% on the same quarter a year earlier. That is the 3rd quarter in a row of profit growth. Full-year FY26 profit was ₹8.0 Cr. Over 5 years profit has grown 76.9% a year on average. That is 13.4% of the quarter's revenue. The same quarter a year earlier earned ₹2.3 Cr. For the full year, FY26 profit was ₹8.0 Cr (+50.8% on the year before). Why profit moved: revenue changed +54.9% on a year earlier and the margin moved −3.0 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed +37.2% and revenue +52.6%. Profit is growing slower than sales: rising costs are taking part of the growth. FY26-Q2. revenue ₹29 Cr and profit ₹3 Cr as reported. FY26-Q4. revenue ₹39 Cr and profit ₹5 Cr as reported. Why-sources: our stock research file (10 October 2026) and the company’s own results for those quarters. ## How much revenue does Qualitek Labs make, and is it growing? Qualitek Labs Ltd reported ₹38.6 Cr of revenue in the Mar 2026 quarter, +54.9% on the same quarter a year earlier. That is the 5th quarter in a row with growth on the year before. Over 5 years it has grown 60.5% a year on average. The last full year, FY26, came in at ₹67.6 Cr. Why this happened. Management proposed an inspection business with a dated start. The potential benefit depends on customer wins, staff costs and collections; competitors' pricing response and retained profit are unknown. The promise is an opportunity to verify rather than delivered incremental cash. FY26 revenue was ₹67.6 Cr, +47.4% on the year before. Recent pace: the last four quarters grew +52.6% on average, against 60.5% a year over the longer run, so this year is growing slower than its own long-run rate. FY26-Q2. revenue ₹29 Cr and profit ₹3 Cr as reported. FY26-Q4. revenue ₹39 Cr and profit ₹5 Cr as reported. Why-sources: our stock research file (10 October 2026) and the company’s own results for those quarters. ## How much of every ₹100 of sales does Qualitek Labs keep? Qualitek Labs Ltd's operating margin was 25.9% in the Mar 2026 quarter, 3.0 percentage points lower than the same quarter a year ago. Over the last four quarters it has moved +0.1 percentage points. Across 6 years it has been between 16.2% and 27.7%. The latest quarter is within that range. Why this happened. The goal provides a measurable hurdle. Its first contribution must appear in comparable operating results and attributable earnings. No separate valuation benefit is assumed merely because management published guidance. Why the margin moved: operating margin changed +0.1 percentage points on the year while gross margin changed −16.6 points. So the gain came mostly from the gross margin, which means input costs and prices charged. FY26-Q2. revenue ₹29 Cr and profit ₹3 Cr as reported. FY26-Q4. revenue ₹39 Cr and profit ₹5 Cr as reported. Why-sources: our stock research file (10 October 2026) and the company’s own results for those quarters. ## Is Qualitek Labs' profit turning into cash? Over the last 3 years, 118% of Qualitek Labs Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹7.2 Cr of operating cash against ₹8.0 Cr of profit. Why this happened. Cash conversion supports the existing earnings base. Collection improvement would preserve more of the operating benefit. After ₹45.0 Cr of spending on assets, free cash was −₹38.0 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 118% of profit came in as cash: the cash cycle got 37 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives. What to look at next: the bigger use of cash is spending on new assets, at 8.3× depreciation over three years. The next section checks what that spending is building. ## Where does Qualitek Labs' cash go? Qualitek Labs Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 106 days in FY26, up from 69 days in FY21. It spent ₹75.0 Cr on assets over the last 3 years. Customers take 106 days to pay, and stock sits for 70 days on average. Why this happened. Operating profit growth accompanies revenue growth, which supports a business contribution to earnings. Full-period subsidiary consolidation prevents treating the entire increase as organic demand. Acquisition scale and utilization are dependent mechanisms and are counted together. At FY26 sales of ₹67.6 Cr, each day of that cycle ties up about ₹0.2 Cr, so roughly ₹20.0 Cr is tied up in the business at any time. FY26: customers took 106 days to pay and stock sat for 70 days, about 2.3 months of sales sitting as stock, for a full cycle of 106 days, longer than FY21's 69. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 70 days. Customers pay about 106 days after that. Suppliers are paid at 206 days. Together that makes the 106-day cycle. Spending on assets: ₹75.0 Cr over the last 3 years, against ₹9.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹41.9 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Qualitek Labs' P/E ratio, and how does it compare with its own history? Qualitek Labs Ltd's P/E is 72.5×, in the middle of its own history: higher than 53% of past readings. Its usual P/E (the middle reading) is 71.3×, over 2.7 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Qualitek Labs business getting better or worse? Qualitek Labs Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 5 quarters of 1 measure, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## What is the Qualitek Labs story, and has it been checked? Qualitek Labs Ltd's story is not scored yet against the checks our research set on 10 October 2026. Where it sits in its own cycle: MID EXPANSION. Still open: A comparable reporting period showing lower operating profit while borrowings and overdue receivables increase would break the case that expansion is creating sustainable shareholder value. Our read, 10 October 2026. Reported expansion is visible, but acquisition effects, funding needs and limited reporting history prevent a confirmed self-funded growth thesis. From the numbers. The operating-stage estimate indicates expansion, but comparable earnings history remains…

From the price. Price stage 2, week 23, above its 200-day line, relative strength rising. From the research. Reported expansion is visible, but acquisition effects, funding needs and limited reporting history prevent a confirmed self-funded growth thesis. Where they disagree. The operating-stage estimate indicates expansion, but comparable earnings history remains insufficient. What is proven. Reported expansion is visible, but acquisition effects, funding needs and limited reporting history prevent a confirmed self-funded growth thesis. What is not proven yet. A comparable reporting period showing lower operating profit while borrowings and overdue receivables increase would break the case that expansion is creating sustainable shareholder value. What would change our mind. A comparable reporting period showing lower operating profit while borrowings and overdue receivables increase would break the case that expansion is creating sustainable shareholder value. The test written in advance. A comparable reporting period showing lower operating profit while borrowings and overdue receivables increase would break the case that expansion is creating sustainable shareholder value. Measured by: the thesis as written as stated by the next result. What the company does. The testing platform has increased reported revenue and operating profit. The deeper question is how much growth remains after consolidation effects, additional shares and funding costs. What the surface reading misses. The surface reading is: Reported annual growth suggests expansion. The research reads it further: Revenue and operating profit moved together, but the consolidation perimeter changed. Reported growth therefore mixes operating delivery with acquired scale. What the surface reading misses. The surface reading is: Profit growth exceeds the acceleration threshold. The research reads it further: Operating-profit growth tracks profit growth, but acquired revenue and additional ownership can explain part of the increase. Sources: our stock research file (10 October 2026) · quarterly results through Mar 2026. The story check is re-scored every results season; the record below never changes. ## How much does Qualitek Labs earn on its capital? Qualitek Labs Ltd earned a ROCE of 8% in FY26. Its return on capital used (ROIC) is 2.4 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 11.8% net margin and 0.30× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 11.8% net margin × 0.30× asset turnover × 1.54× leverage (assets divided by equity) ≈ 5.5% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 9.6% − 12.0% = −2.4 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Qualitek Labs have too much debt? Qualitek Labs Ltd had ₹65.6 Cr of borrowings against ₹146 Cr of equity in FY26, so its debt is 0.45× its equity. Its operating profit is 7 times its interest bill. Over 5 years borrowings went from ₹11.2 Cr to ₹65.6 Cr. Over the last 3 of those years it spent ₹75.0 Cr on assets. Part of the spending on assets is being paid for with borrowed money. ## What is the Qualitek Labs shareholding pattern? Promoters cut their stake in Qualitek Labs Ltd by 16.9 percentage points over 5 quarters, the biggest change among its owners. Promoters now own 56.5% of the company. Foreign institutions moved +1.5 points over the same period, to 1.5%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Promoters: −16.9 points over 5 quarters, to 56.5%; Foreign institutions: +1.5 points over 5 quarters, to 1.5%; Domestic institutions: +0.1 points over 5 quarters, to 0.1%. Why the owners changed: promoters drove it (−16.9 points), with the other side taken by foreign institutions (+1.5 points). They reduced their stake. ## How far is Qualitek Labs from balance-sheet trouble? For Qualitek Labs Ltd, the Z-score is 2.64. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the grey area between the two. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 2.64 is in the grey area, neither clearly safe nor clearly in trouble. ## How does Qualitek Labs rank in its industry? 49.9 out of 100, rank 35 of 40 in Miscellaneous, with 31% of the evidence available. It is provisional, so it is ranked below companies with full evidence. Qualitek Labs Ltd scores 49.9 out of 100 against the 40 companies it is compared with in Miscellaneous, ranking 35. Some evidence is missing, so the score is pulled toward the middle on purpose. The four parts add up to the total exactly: 16.4 + 12.2 + 9.3 + 12 = 49.9. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Qualitek Labs compared with? Qualitek Labs ranks 35 of 40 Miscellaneous companies on the 4-Factor Sector Score, with 49.9 out of 100. 1. [Global Education Ltd](https://www.sectoralpha.in/stocks/global-education-ltd) GLOBAL · breaking out · Most evidence points up · 89% evidence 71.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.1/35 · Revenue 28.2% · Profit 3.3% · Operating margin change 0.3 points · 88% evidence Capital efficiency 21.3/25 · ROCE 29.2% · Operating margin 41% · 100% evidence Valuation 14.4/20 · P/E 28.1× · PEG 0.67 · 65% evidence Relative strength 19.9/20 · Lead over its industry 45% · Lead over NIFTY 500 44.6% · 1 year 103.5% · 100% evidence · 9 of 12 weeks ahead Exact sum: 16.1 + 21.3 + 14.4 + 19.9 = 71.7 · What this means: Relative strength against the index is 44.6%, and revenue and profit growth are weak. 2. [Sagility Ltd](https://www.sectoralpha.in/stocks/sagility-ltd) SAGILITY · losing its lead · Most evidence points up · 78% evidence 66.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 28.5% · Profit 28.4% · Operating margin change 0 points · 100% evidence Capital efficiency 17.4/25 · ROCE 13.4% · Operating margin 25% · 100% evidence Valuation 15.6/20 · P/E 18.6× · PEG 0.37 · 65% evidence Relative strength 9.6/20 · Lead over its industry n/a · Lead over NIFTY 500 -1.3% · 1 year -19.9% · 25% evidence · 9 of 12 weeks ahead Exact sum: 23.6 + 17.4 + 15.6 + 9.6 = 66.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Gulshan Polyols Ltd](https://www.sectoralpha.in/stocks/gulshan-polyols-ltd) GULPOLY · quiet · Evidence leans up · 96% evidence 64.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 26.2/35 · Revenue 9.4% · Profit 100% · Operating margin change 7 points · 88% evidence Capital efficiency 19.4/25 · ROCE 18.6% · Operating margin 13% · 100% evidence Valuation 14.6/20 · P/E 6× · PEG 1.48 · 100% evidence Relative strength 4.4/20 · Lead over its industry -10.5% · Lead over NIFTY 500 -10.4% · 1 year -5.9% · 100% evidence · 1 of 12 weeks ahead Exact sum: 26.2 + 19.4 + 14.6 + 4.4 = 64.6 · What this means: Earnings are strong; relative strength in its sector is -10.5% and the one-year return is -5.9%. 4. [Shree Vasu Logistics Ltd](https://www.sectoralpha.in/stocks/shree-vasu-logistics-ltd) SVLL · leader · Evidence leans up · 64% evidence 62.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.4/35 · Revenue 47.4% · Profit 100% · Operating margin change 0.8 points · 88% evidence Capital efficiency 18.6/25 · ROCE 20.5% · Operating margin 25.8% · 100% evidence Valuation 8.9/20 · P/E 119× · PEG n/a · 15% evidence Relative strength 11.8/20 · Lead over its industry n/a · Lead over NIFTY 500 14% · 1 year -0.9% · 25% evidence · 12 of 12 weeks ahead Exact sum: 23.4 + 18.6 + 8.9 + 11.8 = 62.7 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 5. [R K Swamy Ltd](https://www.sectoralpha.in/stocks/r-k-swamy-ltd) RKSWAMY · Evidence leans up · 69% evidence 62.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 26.0/43.75 · Revenue 14.3% · Profit 17.3% · Operating margin change 2.6 points · 88% evidence Capital efficiency 19.5/31.25 · ROCE 12.3% · Operating margin 10.4% · 100% evidence Valuation 17.0/25 · P/E 19.5× · PEG 0.77 · 65% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 26 + 19.5 + 17 = 62.5 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: There is no relative-strength reading for this week, so the score is built from earnings, capital efficiency and valuation alone. 6. [Aeroflex Enterprises Ltd](https://www.sectoralpha.in/stocks/aeroflex-enterprises-ltd) AEROENTER · turning · Evidence leans up · 71% evidence 61.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.2/35 · Revenue 27.5% · Profit 100% · Operating margin change -5 points · 83% evidence Capital efficiency 13.6/25 · ROCE 12.6% · Operating margin 9% · 76% evidence Valuation 11.4/20 · P/E 9.3× · PEG n/a · 15% evidence Relative strength 17.4/20 · Lead over its industry 28.1% · Lead over NIFTY 500 27.6% · 1 year 43.7% · 100% evidence · 7 of 12 weeks ahead Exact sum: 19.2 + 13.6 + 11.4 + 17.4 = 61.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Blue Water Logistics Ltd](https://www.sectoralpha.in/stocks/blue-water-logistics-ltd) BLUEWATER · Evidence leans up · 64% evidence 60.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.4/35 · Revenue 163.3% · Profit 169.2% · Operating margin change -2 points · 88% evidence Capital efficiency 17.1/25 · ROCE 31.4% · Operating margin 11% · 100% evidence Valuation 10.8/20 · P/E 15.4× · PEG n/a · 15% evidence Relative strength 12.5/20 · Lead over its industry n/a · Lead over NIFTY 500 83.1% · 1 year n/a · 25% evidence Exact sum: 20.4 + 17.1 + 10.8 + 12.5 = 60.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Anlon Technology Solutions Ltd](https://www.sectoralpha.in/stocks/anlon-technology-solutions-ltd) ANLON · breaking out · Too little evidence to rank firmly · 54% evidence 58.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.0/35 · Revenue 100% · Profit 100% · Operating margin change 1 points · 28% evidence Capital efficiency 18.6/25 · ROCE 27.1% · Operating margin 20% · 75% evidence Valuation 7.0/20 · P/E 36× · PEG 1.51 · 100% evidence Relative strength 12.2/20 · Lead over its industry n/a · Lead over NIFTY 500 31.2% · 1 year n/a · 25% evidence · 5 of 5 weeks ahead Exact sum: 21 + 18.6 + 7 + 12.2 = 58.8 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 9. [Eveready Industries India Ltd](https://www.sectoralpha.in/stocks/eveready-industries-india-ltd) EVEREADY · basing · Evidence leans up · 66% evidence 56.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.4/35 · Revenue 9.8% · Profit 100% · Operating margin change -1 points · 74% evidence Capital efficiency 15.6/25 · ROCE 17.2% · Operating margin 12% · 100% evidence Valuation 11.6/20 · P/E 12.9× · PEG n/a · 50% evidence Relative strength 10.0/20 · Lead over its industry n/a · Lead over NIFTY 500 -0.8% · 1 year -18% · 25% evidence · 3 of 12 weeks ahead Exact sum: 19.4 + 15.6 + 11.6 + 10 = 56.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Prozone Realty Ltd](https://www.sectoralpha.in/stocks/prozone-realty-ltd) PROZONER · breaking out · Evidence leans up · 68% evidence 55.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.4/35 · Revenue -9.9% · Profit 100% · Operating margin change 8.2 points · 83% evidence Capital efficiency 7.5/25 · ROCE 6% · Operating margin -35.6% · 76% evidence Valuation 10.0/20 · P/E n/a · PEG n/a · 0% evidence Relative strength 17.0/20 · Lead over its industry 4.5% · Lead over NIFTY 500 5.1% · 1 year -26.8% · 100% evidence · 8 of 12 weeks ahead Exact sum: 21.4 + 7.5 + 10 + 17 = 55.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [TruAlt Bioenergy Ltd](https://www.sectoralpha.in/stocks/trualt-bioenergy-ltd) TRUALT · quiet · Evidence leans up · 68% evidence 53.4 out of 100 Growth Capital Valuation Relative
12. [Jindal Photo Ltd](https://www.sectoralpha.in/stocks/jindal-photo-ltd) JINDALPHOT · turning · Evidence leans up · 76% evidence 53.0 out of 100 Growth Capital Valuation Relative
13. [Aegis Vopak Terminals Ltd](https://www.sectoralpha.in/stocks/aegis-vopak-terminals-ltd) AEGISVOPAK · quiet · Evidence leans up · 60% evidence 52.2 out of 100 Growth Capital Valuation Relative
14. [Jai Corp Ltd](https://www.sectoralpha.in/stocks/jai-corp-ltd) JAICORPLTD · basing · Too little evidence to rank firmly · 56% evidence 51.2 out of 100 Growth Capital Valuation Relative
15. [GMR Airports Ltd](https://www.sectoralpha.in/stocks/gmr-airports-ltd) GMRAIRPORT · quiet · Evidence leans down · 83% evidence 49.1 out of 100 Growth Capital Valuation Relative
16. [Parin Enterprises Ltd](https://www.sectoralpha.in/stocks/parin-enterprises-ltd) PARIN · losing its lead · Evidence leans down · 63% evidence 48.3 out of 100 Growth Capital Valuation Relative
17. [Anzen India Energy Yield Plus Trust](https://www.sectoralpha.in/stocks/anzen-india-energy-yield-plus-trust) ANZEN · losing its lead · Too little evidence to rank firmly · 52% evidence 47.5 out of 100 Growth Capital Valuation Relative
18. [TCC Concept Ltd](https://www.sectoralpha.in/stocks/tcc-concept-ltd) TCC · quiet · Evidence leans down · 71% evidence 47.1 out of 100 Growth Capital Valuation Relative
19. [Shipping Corporation of India Land & Assets Ltd](https://www.sectoralpha.in/stocks/shipping-corporation-of-india-land-assets-ltd) SCILAL · basing · Evidence leans down · 90% evidence 45.5 out of 100 Growth Capital Valuation Relative
20. [Aqylon Nexus Ltd](https://www.sectoralpha.in/stocks/aqylon-nexus-ltd) AQYLON · basing · Evidence leans down · 71% evidence 43.5 out of 100 Growth Capital Valuation Relative
21. [Inox Green Energy Services Ltd](https://www.sectoralpha.in/stocks/inox-green-energy-services-ltd) INOXGREEN · quiet · Evidence leans down · 71% evidence 41.1 out of 100 Growth Capital Valuation Relative
22. [Delta Corp Ltd](https://www.sectoralpha.in/stocks/delta-corp-ltd) DELTACORP · breaking out · Evidence leans down · 67% evidence 41.1 out of 100 Growth Capital Valuation Relative
23. [GKW Ltd](https://www.sectoralpha.in/stocks/gkw-ltd) GKWLIMITED · turning · Evidence leans down · 61% evidence 38.5 out of 100 Growth Capital Valuation Relative
24. [Kaveri Seed Company Ltd](https://www.sectoralpha.in/stocks/kaveri-seed-company-ltd) KSCL · basing · Evidence leans down · 76% evidence 37.3 out of 100 Growth Capital Valuation Relative
25. [IIRM Holdings India Ltd](https://www.sectoralpha.in/stocks/iirm-holdings-india-ltd) IIRM · quiet · Evidence leans down · 64% evidence 36.8 out of 100 Growth Capital Valuation Relative
26. [Unitech Ltd](https://www.sectoralpha.in/stocks/unitech-ltd) UNITECH · basing · Evidence leans down · 68% evidence 35.6 out of 100 Growth Capital Valuation Relative
27. [Stanley Lifestyles Ltd](https://www.sectoralpha.in/stocks/stanley-lifestyles-ltd) STANLEY · quiet · Most evidence points down · 64% evidence 34.3 out of 100 Growth Capital Valuation Relative
28. [Embassy Developments Ltd](https://www.sectoralpha.in/stocks/embassy-developments-ltd) EMBDL · quiet · Most evidence points down · 61% evidence 27.2 out of 100 Growth Capital Valuation Relative
29. [RattanIndia Enterprises Ltd](https://www.sectoralpha.in/stocks/rattanindia-enterprises-ltd) RTNINDIA · basing · Most evidence points down · 61% evidence 24.8 out of 100 Growth Capital Valuation Relative
30. Exhicon Events Media Solutions Ltd losing its lead · Too little evidence to rank firmly · 42% evidence 58.0 out of 100 Growth Capital Valuation Relative
31. [Central Mine Planning & Design Institute Ltd](https://www.sectoralpha.in/stocks/central-mine-planning-design-institute-ltd) CMPDI · quiet · Too little evidence to rank firmly · 38% evidence 57.3 out of 100 Growth Capital Valuation Relative
32. [Take Ltd](https://www.sectoralpha.in/stocks/take-solutions-ltd) TAKE · Too little evidence to rank firmly · 38% evidence 55.8 out of 100 Growth Capital Valuation Relative
33. [Fabtech Cleanrooms Ltd](https://www.sectoralpha.in/stocks/fabtech-cleanrooms-ltd) breaking out · Too little evidence to rank firmly · 41% evidence 54.8 out of 100 Growth Capital Valuation Relative
34. [Devson Catalyst Ltd](https://www.sectoralpha.in/stocks/devson-catalyst-ltd) Too little evidence to rank firmly · 15% evidence 52.9 out of 100 Growth Capital Valuation Relative
35. Qualitek Labs Ltd this page breaking out · Too little evidence to rank firmly · 31% evidence 49.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.4/35 · Revenue n/a · Profit n/a · Operating margin change -3 points · 15% evidence Capital efficiency 12.2/25 · ROCE 7.5% · Operating margin 25.9% · 71% evidence Valuation 9.3/20 · P/E 71.5× · PEG n/a · 15% evidence Relative strength 12.0/20 · Lead over its industry n/a · Lead over NIFTY 500 25.3% · 1 year n/a · 25% evidence · 10 of 12 weeks ahead Exact sum: 16.4 + 12.2 + 9.3 + 12 = 49.9 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 36. [Indiqube Spaces Ltd](https://www.sectoralpha.in/stocks/indiqube-spaces-ltd) INDIQUBE · turning · Too little evidence to rank firmly · 46% evidence 47.7 out of 100 Growth Capital Valuation Relative
37. [Maagh Advertising & Marketing Services Ltd](https://www.sectoralpha.in/stocks/maagh-advertising-marketing-services-ltd) Too little evidence to rank firmly · 21% evidence 47.5 out of 100 Growth Capital Valuation Relative
38. [Lords Mark Industries Limited](https://www.sectoralpha.in/stocks/lords-mark-industries-limited) quiet · Too little evidence to rank firmly · 43% evidence 45.7 out of 100 Growth Capital Valuation Relative
39. [Tandhan Industries Ltd](https://www.sectoralpha.in/stocks/tandhan-industries-ltd) turning · Too little evidence to rank firmly · 37% evidence 42.4 out of 100 Growth Capital Valuation Relative
40. [Shree Rama Newsprint Ltd](https://www.sectoralpha.in/stocks/shree-rama-newsprint-ltd) RAMANEWS · Too little evidence to rank firmly · 48% evidence 32.5 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Miscellaneous](https://www.sectoralpha.in/sectors/miscellaneous), all 40 compared on one page. ## Which companies are close to Qualitek Labs in size? Qualitek Labs is the 31st largest of 40 Miscellaneous companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Stanley Lifestyles, Global Education and IIRM Holdings India. Just below it: Maagh Advertising & Marketing Services, Blue Water Logistics and Fabtech Cleanrooms. ### Miscellaneous companies close in size

1. [Stanley Lifestyles Ltd](https://www.sectoralpha.in/stocks/stanley-lifestyles-ltd) ₹739 crore
2. [Global Education Ltd](https://www.sectoralpha.in/stocks/global-education-ltd) ₹732 crore
3. [IIRM Holdings India Ltd](https://www.sectoralpha.in/stocks/iirm-holdings-india-ltd) ₹728 crore
4. Qualitek Labs Ltd ₹577 crore
5. [Maagh Advertising & Marketing Services Ltd](https://www.sectoralpha.in/stocks/maagh-advertising-marketing-services-ltd) ₹572 crore
6. [Blue Water Logistics Ltd](https://www.sectoralpha.in/stocks/blue-water-logistics-ltd) ₹550 crore
7. [Fabtech Cleanrooms Ltd](https://www.sectoralpha.in/stocks/fabtech-cleanrooms-ltd) ₹548 crore

[All 40 Miscellaneous companies, largest first](https://www.sectoralpha.in/sectors/miscellaneous#all-companies)

### Companies close in size in other industries

1. [Goel Construction Company Ltd](https://www.sectoralpha.in/stocks/goel-construction-company-ltd) ₹578 crore · Engineering - Turnkey Services
2. [JTL Defence Ltd](https://www.sectoralpha.in/stocks/jtl-defence-ltd) ₹578 crore · Metal - Copper/Copper Alloy Products
3. Qualitek Labs Ltd ₹577 crore
4. [Voith Paper Fabrics India Ltd](https://www.sectoralpha.in/stocks/voith-paper-fabrics-india-ltd) ₹577 crore · Textiles - General
5. [Artson Ltd](https://www.sectoralpha.in/stocks/artson-ltd) ₹576 crore · Infra - Engineering - General

## What else do people ask about Qualitek Labs? ### What is Qualitek Labs's share price today? Qualitek Labs Ltd's share price is ₹502.00. The whole company is worth ₹585 Cr on the market. In the last 52 weeks it traded between ₹340 to ₹621; today it is 58% of the way up from the low, 12.9% above its 200-day average. The price has been rising for 23 weeks (as of 3 November 2026). ### What were Qualitek Labs's latest quarterly results? Qualitek Labs Ltd reported revenue of ₹38.6 Cr and net profit of ₹5.2 Cr for the Mar 2026 quarter. Revenue rose 54.9% and profit rose 44.8% compared with a year earlier. Earnings per share were ₹4.44. The operating margin was 25.9%, 3.0 percentage points lower than a year earlier (as of 3 November 2026). ### What is Qualitek Labs's market cap? Qualitek Labs Ltd's market capitalisation is ₹585 Cr at a share price of ₹502.00. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Qualitek Labs performing? Qualitek Labs Ltd's share price has been rising for 23 weeks. In its latest quarter, revenue rose 54.9% and profit rose 44.8% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 16 weeks running (as of 3 November 2026). ### Is Qualitek Labs in an uptrend? Yes, the price has been rising for 23 weeks (stage 2 of 4), 12.9% above its 200-day average, and 58% of the way up its 52-week range. A share price tends to move through four phases: moving sideways, rising, stalling and falling (as of 3 November 2026). ### Will Qualitek Labs's share price go up? This page does not forecast Qualitek Labs Ltd's share price. What it shows instead: the share price is ₹502.00, and it has been rising for 23 weeks. Its P/E of 72.5× is higher than 53% of its own last 3 years (as of 3 November 2026). ### Who owns Qualitek Labs? Promoters own 56.5% of Qualitek Labs Ltd, foreign institutions 1.5%, domestic institutions 0.1% and the public 41.9% (latest quarter). The biggest change over the last two years: Promoters cut their stake by 16.9 percentage points over 5 quarters (as of 3 November 2026). ### Where is Qualitek Labs in its business cycle? Qualitek Labs Ltd's FY26 operating margin was 24.6%, against a 6-year range of 16.2% to 27.7%: the middle of its own range, neither a peak nor a low. The latest quarter was 25.9%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Qualitek Labs story? The main question: promoters moved −16.9 percentage points over 5 quarters while the business went the other way. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Qualitek Labs a stock worth studying right now? What the numbers show: Qualitek Labs Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether the owners’ moves turn back in line with the business. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ### Is there a Qualitek Labs share price forecast for 2026? What is changing at Qualitek Labs, from the latest results and calls: reported platform expansion, potential improvement in service economics and cash conversion of existing earnings. What would change the story: A comparable reporting period showing lower operating profit while borrowings and overdue receivables increase would break the case that expansion is creating sustainable shareholder value. ## Lists

- Multibagger study list: https://www.sectoralpha.in/multibagger-stocks-india

This is research, not advice. We’re not SEBI-registered.